Skip to main content
. Author manuscript; available in PMC: 2020 Jan 14.
Published in final edited form as: Cancer. 2011 Oct 17;118(13):3426–3432. doi: 10.1002/cncr.26587

Figure 2.

Figure 2.

(A) Mir-100, overall benign vs malignant samples, fitted ROC area: 0.703. (B) Mir-100, benign vs malignant Hürthle cell samples, fitted ROC area: 0.837. (C) Mir-125b, overall benign vs malignant samples, fitted ROC area: 0.689. (D) Mir-125b, benign vs malignant follicular samples, fitted ROC area: 0.717. (E) Mir-125b, benign vs malignant Hürthle cell samples, fitted ROC area: 0.903. (F) Mir-138, overall benign vs malignant samples, fitted ROC area: 0.791. (G) Mir-138, benign vs malignant Hürthle cell samples, fitted ROC area: 0.978. (H) Mir-768–3p, overall benign vs malignant samples, fitted ROC area: 0.785. (I) Mir-768–3p, benign vs malignant Hürthle cell samples, fitted ROC area: 0.978.